Mufg Americas Holdings Corp Novo Nordisk A S Transaction History

Mufg Americas Holdings Corp

$0
Q3 2023

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 01, 2022	SELL	$95.28 - $116.93 $31,442 - $38,586	-330 Reduced 19.93%	1,326 $132,000
Q3 2022 Oct 31, 2022	SELL	$95.28 - $116.93 $31,442 - $38,586	-330 Reduced 19.93%	1,326 $132,000
Q2 2022 Dec 01, 2022	SELL	$103.24 - $121.81 $26,429 - $31,183	-256 Reduced 13.39%	1,656 $185,000
Q2 2022 Aug 02, 2022	SELL	$103.24 - $121.81 $26,429 - $31,183	-256 Reduced 13.39%	1,656 $185,000
Q1 2022 Dec 01, 2022	SELL	$93.1 - $112.54 $218,691 - $264,356	-2,349 Reduced 55.13%	1,912 $212,000
Q1 2022 May 06, 2022	SELL	$93.1 - $112.54 $218,691 - $264,356	-2,349 Reduced 55.13%	1,912 $212,000
Q4 2021 Dec 01, 2022	SELL	$95.88 - $117.08 $166,831 - $203,719	-1,740 Reduced 29.0%	4,261 $477,000
Q4 2021 Feb 09, 2022	SELL	$95.88 - $117.08 $166,831 - $203,719	-1,740 Reduced 29.0%	4,261 $477,000
Q3 2021 Dec 01, 2022	SELL	$84.42 - $106.62 $114,220 - $144,256	-1,353 Reduced 18.4%	6,001 $576,000
Q3 2021 Nov 05, 2021	SELL	$84.42 - $106.62 $114,220 - $144,256	-1,353 Reduced 18.4%	6,001 $576,000
Q2 2021 Dec 01, 2022	SELL	$67.66 - $84.76 $1.16 Million - $1.46 Million	-17,198 Reduced 70.05%	7,354 $616,000
Q2 2021 Aug 06, 2021	SELL	$67.66 - $84.76 $1.16 Million - $1.46 Million	-17,198 Reduced 70.05%	7,354 $616,000
Q1 2021 Dec 01, 2022	SELL	$67.06 - $75.82 $266,228 - $301,005	-3,970 Reduced 13.92%	24,552 $1.66 Million
Q1 2021 Apr 30, 2021	SELL	$67.06 - $75.82 $266,228 - $301,005	-3,970 Reduced 13.92%	24,552 $1.66 Million
Q4 2020 Dec 01, 2022	BUY	$63.89 - $73.8 $97,623 - $112,766	1,528 Added 5.66%	28,522 $1.99 Million
Q4 2020 Feb 03, 2021	BUY	$63.89 - $73.8 $97,623 - $112,766	1,528 Added 5.66%	28,522 $1.99 Million
Q3 2020 Dec 01, 2022	BUY	$63.69 - $70.22 $129,354 - $142,616	2,031 Added 8.14%	26,994 $1.87 Million
Q3 2020 Nov 03, 2020	BUY	$63.69 - $70.22 $129,354 - $142,616	2,031 Added 8.14%	26,994 $1.87 Million
Q2 2020 Dec 01, 2022	BUY	$58.54 - $67.94 $1.38 Million - $1.61 Million	23,637 Added 1782.58%	24,963 $1.63 Million
Q2 2020 Aug 06, 2020	BUY	$58.54 - $67.94 $127,500 - $147,973	2,178 Added 9.56%	24,963 $1.63 Million
Q1 2020 Apr 24, 2020	SELL	$49.46 - $64.78 $258,379 - $338,410	-5,224 Reduced 18.65%	22,785 $1.37 Million
Q4 2019 Feb 10, 2020	BUY	$49.86 - $58.26 $565,960 - $661,309	11,351 Added 68.14%	28,009 $1.62 Million
Q3 2019 Nov 06, 2019	BUY	$47.54 - $53.43 $318,660 - $358,141	6,703 Added 67.33%	16,658 $861,000
Q2 2019 Aug 09, 2019	SELL	$46.79 - $52.47 $15,300 - $17,157	-327 Reduced 3.18%	9,955 $508,000
Q1 2019 May 13, 2019	BUY	$46.36 - $52.63 $7,139 - $8,105	154 Added 1.52%	10,282 $538,000
Q4 2018 Feb 13, 2019	SELL	$41.54 - $47.25 $61,271 - $69,693	-1,475 Reduced 12.71%	10,128 $466,000
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $472,416 - $517,677	10,103 Added 673.53%	11,603 $0
Q1 2018 May 07, 2018	SELL	$48.49 - $58.14 $61,630 - $73,895	-1,271 Reduced 45.87%	1,500 $74,000
Q4 2017 Feb 08, 2018	SELL	$47.53 - $53.73 $10,884 - $12,304	-229 Reduced 7.63%	2,771 $0
Q2 2017 Aug 07, 2017	BUY	N/A	3,000	3,000 $0

Others Institutions Holding NVO

# of Institutions

1,954

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$2.12 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.51 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.51 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.4 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.28 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.

Account